ArticleMedical oncology (Northwood, London, England)2023

A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer.

HemaNandini Rajendran Krishnamoorthy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.